Fedley Healthcare: India's Trusted Rabeprazole 40mg + Domperidone 10mg Tablet

DCGI Approved WHO-GMP
Tablets & Capsules

RABIRIV-D

Product Composition

Rabeprazole 40mg + Domperidone 10mg Tablet

Packing
10*10
Release Type
ALU/ALU
DCGI Approved
WHO-GMP Certified
ALU/ALU
Pan India Delivery
Get Franchise QuoteWhatsApp Us
ISO 9001:2015
1000+ Products
29+ States
Share:

Uses of RABIRIV-D

Rabeprazole 40mg + Domperidone 10mg Tablet is prescribed for various conditions related to inflammation, pain, and joint disorders.

Quality-Driven Manufacturing Behind RABIRIV-D

1000+
DCGI Approved Products
12+
Years of Experience
2000+
Franchise Partners
29+
States Covered

PCD Pharma Franchise for Rabeprazole 40mg + Domperidone 10mg Tablet — Available Across India

Fedley Healthcare provides exclusive monopoly-based PCD franchise rights for RABIRIV-D in all major states and union territories across India.

PunjabHaryanaRajasthanUttar PradeshMadhya PradeshGujaratMaharashtraKarnatakaTamil NaduKeralaAndhra PradeshTelanganaWest BengalBiharJharkhandOdishaChhattisgarhAssamMeghalayaTripuraManipurNagalandMizoramArunachal PradeshSikkimUttarakhandHimachal PradeshGoaJammu & KashmirDelhi NCRChandigarhPuducherry

Exclusive monopoly rights available — contact us to check availability in your state & district.

Why Fedley Healthcare vs Other Manufacturers?

See how we compare with typical pharma manufacturers in India.

Factor
Fedley Healthcare
Others
WHO-GMP Certification
Certified
Often Not
DCGI Approved Products
1000+
Limited
Monopoly Rights
Exclusive Territory
Shared
Marketing Support
Visual Aids, LBLs, Gifts
Minimal / Paid
Product Quality
SR Technology
Standard
Delivery
Pan India, On-Time
Delayed
MOQ (Min Order)
Flexible & Low
High Minimum
Profit Margins
Attractive (High ROI)
Thin Margins
Ethical Promotion
100% Ethical
Questionable
Franchise Support
Dedicated Manager
No Post-Sale Support
WHO-GMP Certification
Fedley
Certified
Others
Often Not
DCGI Approved Products
Fedley
1000+
Others
Limited
Monopoly Rights
Fedley
Exclusive Territory
Others
Shared
Marketing Support
Fedley
Visual Aids, LBLs, Gifts
Others
Minimal / Paid
Product Quality
Fedley
SR Technology
Others
Standard
Delivery
Fedley
Pan India, On-Time
Others
Delayed
MOQ (Min Order)
Fedley
Flexible & Low
Others
High Minimum
Profit Margins
Fedley
Attractive (High ROI)
Others
Thin Margins
Ethical Promotion
Fedley
100% Ethical
Others
Questionable
Franchise Support
Fedley
Dedicated Manager
Others
No Post-Sale Support

Start Your Pharma Business with RABIRIV-D — Get Exclusive Franchise Rights in Your State Today

Join 2000+ successful franchise partners across India. Low investment, high returns, complete marketing support.

Get Franchise Quote Now

Get Franchise Quote for RABIRIV-D

Interested in Rabeprazole 40mg + Domperidone 10mg Tablet for your pharma franchise business? Fill the form and our team will get back to you with pricing, MOQ, and exclusive territory details.

  • Exclusive Monopoly Rights in Your Territory
  • Attractive Profit Margins & Low Investment
  • Timely Product Delivery Across India
  • Free Promotional Support (Visual Aids, LBLs, Gifts)

Send Enquiry

Fill in your details and we'll contact you shortly.

Product: RABIRIV-D | Rabeprazole 40mg + Domperidone 10mg Tablet

Or call us: +91-9855986633 | +91-9317692852

Customer Reviews

4.6based on 99 ratings

RABIRIV-D stands out for its quality manufacturing. The Rabeprazole 40mg + Domperidone 10mg Tablet composition is effective and I have seen good patient compliance with this formulation.

DD

Dr. Deepak Tiwari

Verified Purchase

22 Jan 2026

RABIRIV-D has shown excellent results in my clinical practice. The Rabeprazole 40mg + Domperidone 10mg Tablet formulation is well-balanced and patients report good tolerance with consistent therapeutic outcomes.

SD

Sanjay Dhawan

Verified Purchase

8 Jul 2025

RABIRIV-D from Fedley Healthcare is a dependable product. Rabeprazole 40mg + Domperidone 10mg Tablet — the composition is clinically relevant and competitively priced for franchise partners.

DA

Dr. Anil Mehta

Verified Purchase

20 Oct 2025